Nerve Signal Neuromedin U Shields Aggressive Prostate Cancer From Immune Attack
Wistar Institute researchers found that the neurotransmitter neuromedin U suppresses T cell infiltration at the earliest stage of neuroendocrine prostate cancer, and blocking it restored sensitivity to immunotherapy in experimental models.